Brief: Chimeric Therapeutics Seeks Trading Halt Pending Announcements In Relation To A Capital Raising, Non-Dilutionary Funding
27/02/2025 01:41
Feb 27 (Reuters) - Chimeric Therapeutics Ltd CHM.AX: SEEKS TRADING HALT PENDING ANNOUNCEMENTS IN RELATION TO A CAPITAL RAISING, NON-DILUTIONARY FUNDING Further company coverage: CHM.AX ((Reuters.Briefs@thomsonreuters.com))
Recent news on Chimeric Therapeutics
See all newsBrief: Chimeric Therapeutics Says Phillip Hains Appointed Interim Chairman
Brief: Chimeric Therapeutics Posts Prelim Loss For Year Of A$18.8 MLN
Brief: Chimeric Therapeutics Intends To Enter Negotiations With Its Creditors
Brief: Chimeric Therapeutics Seeks Trading Halt
Australia's Chimeric Therapeutics rises on positive data for its cell therapy clinical trial